Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BATON-BC: Tivozanib + Paclitaxel in TNBC
NCT01745367Phase 2Terminated
- Sponsor
- AVEO Oncology
- Start
- Nov 2012
- Primary completion
- Jun 2014
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 2 trial of tivozanib in triple-negative breast cancer (TNBC), sponsored by AVEO Oncology. Started Nov 2012; status: terminated.
02
Drugs
tivozanib
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT01745367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745367.